Figure 1.
Figure 1. Cohort selected for capture sequencing. (A) Biopsies from de novo DLBCL or tFL with DLBCL morphology were selected for inclusion if they were break-apart positive (BA+) at the MYC locus using the Vysis and/or Dako FISH assays. Cases with no available FFPE tissue were excluded, leaving a total of 112 cases. (B) The FISH break-apart (BA) status of the 112 cases are summarized. Cases in red boxes represent those successfully assessed with the Dako assay. ND, not done.

Cohort selected for capture sequencing. (A) Biopsies from de novo DLBCL or tFL with DLBCL morphology were selected for inclusion if they were break-apart positive (BA+) at the MYC locus using the Vysis and/or Dako FISH assays. Cases with no available FFPE tissue were excluded, leaving a total of 112 cases. (B) The FISH break-apart (BA) status of the 112 cases are summarized. Cases in red boxes represent those successfully assessed with the Dako assay. ND, not done.

Close Modal

or Create an Account

Close Modal
Close Modal